Modeling amyloid-beta as homogeneous dodecamers and in complex with cellular prion protein

Steven L Gallion1

  • 1Wallingford, Connecticut, United States of America. sgallion@comcast.net

Plos One
|November 13, 2012
PubMed

Insights

Soluble amyloid beta (Aβ) oligomers, implicated in Alzheimer's disease, can be less ordered and still stable. Molecular dynamics simulations suggest these less ordered forms are viable and may interact with the prion protein (PrP(c)).

Area of Science:

  • Neuroscience
  • Biochemistry
  • Computational Biology

Background:

  • Soluble amyloid beta (Aβ) oligomers are linked to Alzheimer's disease pathology.
  • The exact toxic structure of Aβ oligomers remains unclear, with evidence for both ordered and disordered forms.
  • The interaction between Aβ oligomers and the cellular prion protein (PrP(c)) is a recent area of investigation.

Purpose of the Study:

  • To investigate the structural stability and characteristics of dodecameric Aβ assemblies using molecular dynamics simulations.
  • To explore the potential role of less ordered Aβ oligomers in Alzheimer's disease.
  • To propose a model for the interaction between Aβ dimers and a PrP(c) N-terminal mutant.

Main Methods:

  • Molecular dynamics simulations of dodecameric Aβ assemblies with specific monomeric structures.
  • Analysis of structural stability, intermolecular interactions, and conformational changes.
  • Development of a tentative model for Aβ dimer binding to a PrP(c) mutant.

Main Results:

  • Aβ assemblies with antiparallel β-hairpins at the C-terminus, lacking intermolecular hydrogen bonds, demonstrated stability.
  • The N-termini of Aβ monomers adopted a random coil state, indicating less ordered structures are stable.
  • A model for Aβ dimer interaction with the N-terminus of PrP(c) was proposed.

Conclusions:

  • Highly ordered assemblies are not essential for Aβ oligomer stability; less ordered forms are viable in solution.
  • The findings support the role of less ordered Aβ oligomers in Alzheimer's disease pathogenesis.
  • The proposed Aβ-PrP(c) interaction model may guide future research and experimental design.